Earnings summaries and quarterly performance for Currenc Group.
Research analysts covering Currenc Group.
Recent press releases and 8-K filings for CURR.
Currenc Group Inc. Announces First Half 2025 Financial Results
CURR
Earnings
New Projects/Investments
Demand Weakening
- Currenc Group Inc. announced its financial results for the first half of 2025, reporting a net loss of US$9.5 million and a total EBITDA loss of US$6.2 million.
- Total Revenues, excluding TNG Asia and GEA, were US$18.8 million for the first half of 2025, representing a 10.8% decrease year-over-year, primarily due to a decline in global and Indonesian airtime revenue.
- Total Processing Value (TPV) through Tranglo was US$2.8 billion for the first half of 2025, decreasing by 5.8% year-over-year.
- Operating expenses increased to US$15.1 million for the first half of 2025 from US$11.0 million in the same period of 2024, mainly due to US$4.3 million in incentive shares granted to employees and US$1.5 million for developing new AI product offerings.
- The company plans to deemphasize airtime transfer and reallocate resources and capital to expand its new AI product offerings.
6 days ago
Currenc Group Inc. Announces Q3 2025 Unaudited Financial Results
CURR
Earnings
New Projects/Investments
M&A
- Currenc Group Inc. reported a net profit attributable to the company of US$2.91 million for the third quarter ended September 30, 2025, a significant turnaround from a net loss of US$19.83 million in the same period of 2024. The company's total EBITDA for Q3 2025 was a profit of US$3.6 million.
- Total revenues, excluding divested entities, decreased 3.9% year-over-year to US$10.4 million for Q3 2025, primarily due to lower Indonesian Airtime revenue. This was partly offset by a 54.8% increase in remittance revenue to US$7.0 million, driven by a 10.1% year-over-year increase in Total Processing Value (TPV) to US$1.41 billion through Tranglo.
- The company's gross profit margin improved to 50.8% in Q3 2025 from 27.8% in Q3 2024, largely due to a 37.0% decrease in direct costs of revenue and a significant reduction in total operating expenses to US$0.5 million from US$19.1 million.
- Currenc is strategically shifting focus, deemphasizing lower-margin airtime transfers to reallocate resources towards new AI product offerings, and is progressing with a proposed reverse merger with Animoca Brands.
Nov 10, 2025, 2:29 PM
SCIENTURE Announces Arbli™ Formulary Inclusion, Expanding Coverage
CURR
Product Launch
- SCIENTURE HOLDINGS, INC. announced on November 04, 2025, that Arbli™ (losartan potassium) Oral Suspension, 10 mg/mL, has been added to the formularies of key national payors.
- This inclusion expands access to over 100 million covered lives across the United States through multiple commercial coverage and Medicare supplement plans.
- Arbli™ is the first FDA-approved, ready-to-use oral suspension formulation of losartan potassium, targeting a U.S. losartan market that totaled approximately $256 million in annual sales with over 71 million prescriptions as of June 2025.
Nov 4, 2025, 1:05 PM
Currenc Group Announces Proposed Reverse Merger with Animoca Brands
CURR
M&A
New Projects/Investments
- Currenc Group Inc. announced a proposed reverse merger with Animoca Brands Corporation Limited, aiming to create the world's first publicly-listed digital assets conglomerate.
- Upon completion, shareholders of Animoca Brands are expected to collectively own approximately 95% of the resulting entity, while current Currenc shareholders would hold approximately 5%.
- The transaction is anticipated to close in the third quarter of 2026, subject to shareholder and regulatory approvals.
- Currenc intends to divest its existing AI-powered solutions for financial institutions and digital remittance platform to its current shareholders prior to the merger's closing.
Nov 3, 2025, 1:00 PM
Currenc Group Announces Convertible Note Financing
CURR
Debt Issuance
New Projects/Investments
- Currenc Group Inc. has announced an agreement to issue and sell up to $33.0 million in unsecured convertible promissory notes due October 8, 2027.
- An initial $4.4 million of the principal amount has already closed, providing $4.0 million in net proceeds to the company.
- The notes bear interest at 5.00% per annum and include 50% warrant coverage with an exercise price of $1.85 per share.
- The company expects to use the proceeds for general corporate purposes, including working capital and growth initiatives, and may repay existing indebtedness.
Oct 14, 2025, 12:22 PM
Angelini Ventures Leads Investment in Serenis
CURR
New Projects/Investments
Revenue Acceleration/Inflection
- Angelini Ventures led a €12 million follow-on investment in Serenis, a digital mental and physical health company, with CDP Venture Capital as co-lead investor.
- Serenis, founded in 2021, has rapidly expanded its network to over 2,500 licensed professionals, supported over 170,000 people, and serves more than 250 companies through corporate wellbeing programs.
- The company demonstrated strong revenue growth, from €2 million in 2022 to €25 million in 2024, with a run-rate already above €40 million in 2025.
- This investment aims to accelerate Serenis’ innovation in digital care services, strengthen its proprietary technologies, and expand its leadership in delivering solutions to corporate clients.
Oct 3, 2025, 8:01 AM
Quarterly earnings call transcripts for Currenc Group.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more